Developer of small-molecule drugs intended to treat autoimmune and inflammatory diseases. The company's drugs eliminate harmful foreign pathogens while being tolerant of self-tissues and organs that s...

Healthcare
Cambridge, MA, United States
Founded 2013
11 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$51.5M
Last Round
N/A

Get the full picture

Create a free account to unlock Artax Biopharma's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required